Michal Skrzypek
Overview
Explore the profile of Michal Skrzypek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
487
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jurkiewicz M, Szczurek-Wasilewicz W, Skrzypek M, Krych S, Gasior M, Szygula-Jurkiewicz B
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941479
: Risk stratification in elderly patients with heart failure (HF) is very difficult. There is a lack of reliable tools for assessing the risk of death in this population of...
2.
Szczurek-Wasilewicz W, Jurkiewicz M, Skrzypek M, Romuk E, Jozwiak J, Gasior M, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796029
Biomarkers are critical for heart failure (HF) management by facilitating risk stratification, therapeutic decision-making, and monitoring treatment response. This prospective, single-center study aimed to assess predictors of death during one-year...
3.
Nowak J, Jabczyk M, Skrzypek M, Brukalo K, Hudzik B, Zubelewicz-Szkodzinska B
Med Sci Monit
. 2024 Dec;
30:e946316.
PMID: 39722437
BACKGROUND Effective assessment and diagnosis using simple nutritional screening tools are crucial for identifying malnutrition in older adults. The aim of the study was to evaluate how effectively different anthropometric...
4.
Kowal K, Skrzypek M
PLoS One
. 2024 Nov;
19(11):e0310501.
PMID: 39536012
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder, whose clinical picture is dominated by visible body changes as well as numerous somatic and behavioural abnormalities. Aim: The...
5.
Dyrbus M, Machowicz J, Pyka L, Adamowicz-Czoch E, Sokola K, Pres D, et al.
Kardiol Pol
. 2024 Oct;
82(12):1239-1246.
PMID: 39440742
Background: Cardiac resynchronization therapy defibrillators (CRT-D) are a cornerstone of the treatment of heart failure and wide QRS. In such subjects, there is often concomitant right ventricular (RV) dysfunction. Aims:...
6.
Dyrbus K, Medrala Z, Konsek K, Nowowiejska-Wiewiora A, Trzeciak P, Skrzypek M, et al.
Arch Med Sci
. 2024 Oct;
20(4):1069-1076.
PMID: 39439677
Introduction: Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Increased Lp(a) concentration > 30 mg/dl (75 nmol/l) and especially >50 mg/dl (125 nmol/l) may cause faster...
7.
Kuczaj A, Skrzypek M, Hudzik B, Kaczmarski J, Pawlak S, Hrapkowicz T, et al.
Sci Rep
. 2024 Aug;
14(1):20193.
PMID: 39214985
Patients on left ventricular assist devices (LVAD) are prone to excessive hemostasis disturbances due to permanent contact of artificial pump surfaces with blood components. We aimed to investigate if fibrin...
8.
Smyla-Gruca W, Szczurek-Wasilewicz W, Skrzypek M, Romuk E, Karmanski A, Jurkiewicz M, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200231
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and cells' ability to neutralize them by antioxidant systems. The role of oxidative stress in hypertrophic cardiomyopathy...
9.
Szczurek-Wasilewicz W, Warmusz O, Skrzypek M, Karmanski A, Jurkiewicz M, Wyrobiec P, et al.
Kardiol Pol
. 2024 Jun;
82(7-8):741-748.
PMID: 38845423
Background: Growth differentiation factor-15 (GDF-15) is a hormone that regulates inflammatory responses, tissue repair, and cardiac remodeling, the three key processes underlying the development and progression of heart failure (HF)....
10.
Szczurek-Wasilewicz W, Skrzypek M, Karmanski A, Jurkiewicz M, Gasior M, Szygula-Jurkiewicz B
Pol Arch Intern Med
. 2024 May;
134(7-8).
PMID: 38804895
Introduction: Accurate risk assessment in patients with heart failure (HF) is crucial. Developing new models that combine biochemical and clinical variables with novel biomarkers is the best approach to improving...